Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› USA
Clinical trial register · United States · industry-sponsored

Clinical Trials in the USA: Industry-Sponsored Studies

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9123 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 06 Nov 2026, 03:16 UTC
9123
Studies in scope
industry-sponsored, all four open statuses
4958
Recruiting now
open to new participants
2179
Lead sponsors
across recruiting studies
Top states
California 5300 Florida 4469 Illinois 2481 Georgia 2360 Arizona 2255
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca294 Novartis Pharmaceuticals202 Eli Lilly and Company200 Merck Sharp & Dohme LLC182 AbbVie175
State
California5300 Florida4469 Illinois2481 Georgia2360 Arizona2255
All 51 states
Target enrolment
to

Trials in this register

9123 of 9123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Active, closed
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
NCT03899792Medullary Thyroid Cancer, Infantile Myofibromatosis, Infantile Fibrosarcoma, Papillary Thyroid Cancer
DrugSelpercatinib
Eli Lilly and Company
Phase 1/2
36
California, Colorado, Florida, Massachusetts, Minnesota, New York, Ohio, Pennsylvania
2019-06-13
Active, closed
BioMarin Pharmaceutical
Phase 2
73
California, Delaware, Georgia, Illinois, Ohio, Tennessee, Texas, Wisconsin
2019-06-12
Active, closed
Syntrix Biosystems, Inc.
Phase 1
77
Florida, Massachusetts, Minnesota, New York, Texas
2019-06-12
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana, Massachusetts
2019-06-11
Active, closed
Boston Scientific Corporation
Not applicable
1,948
Alabama, Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Illinois
2019-06-10
Recruiting
Prolaio
Observational
2,000
Arizona, California, Delaware, Florida, Illinois, Minnesota, Texas, Utah
2019-06-06
Active, closed
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
NCT03957252Prostate Cancer, Prostate Cancer Screening, Performance Assessment of Novel Test
Nanostics
Observational
2,800
Maryland
2019-06-06
Recruiting
Gedeon Richter Plc.
Phase 3
330
California, Georgia, Michigan, Mississippi, New York, Ohio, Texas
2019-06-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Arizona, California, District of Columbia, Florida, Georgia, Illinois, Kentucky, Maryland
2019-06-04
Active, closed
Eisai Inc.
Phase 2
100
California, Colorado, Florida, Georgia, Michigan, New Jersey, North Carolina, Ohio
2019-05-31
By invitation
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
NCT03999801Neovascular Age-related Macular Degeneration, Wet Macular Degeneration
AbbVie
Phase 2
865
Arizona, California, Maryland, Massachusetts, Nevada, Pennsylvania, Tennessee, Texas
2019-05-31
Active, closed
Cellenkos, Inc.
Phase 1
18
California, Texas
2019-05-30
Active, closed
LEO Pharma
Phase 2
131
Michigan, New York
2019-05-29
Active, closed
Nuvaira, Inc.
Not applicable
464
Alabama, Arizona, California, Florida, Illinois, Kentucky, Massachusetts, Michigan
2019-05-23
Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
NCT03808922Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19
Ansun Biopharma, Inc.
Phase 3
274
California, Illinois, Iowa, Kansas, Maryland, Massachusetts, Minnesota, Missouri
2019-05-23
Active, closed
Imara, Inc.
Phase 2
30
Connecticut, Florida, Texas
2019-05-22
Active, closed
Smith & Nephew, Inc.
Observational
118
Minnesota, Missouri
2019-05-22
Active, closed
Glycotest, Inc.
Observational
766
California, Florida, Illinois, Maryland, Michigan, Minnesota, New York, Pennsylvania
2019-05-22
Recruiting
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
NCT05181826Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B
Helio Genomics
Observational
1,200
California, Minnesota, Tennessee, Texas
2019-05-21
Active, closed
AbbVie
Phase 1
150
Arkansas, California, Connecticut, Florida, Indiana, Missouri, North Carolina, Pennsylvania
2019-05-21
Active, closed
Celgene
Phase 1/2
438
Arizona, Florida, Kansas, Minnesota, Missouri, New Jersey, Texas
2019-05-20
Active, closed
StimScience Inc.
Not applicable
1,000
California
2019-05-20
Active, closed
Precigen, Inc
Phase 1
88
Florida, Minnesota
2019-05-20
Recruiting
Immatics US, Inc.
Phase 1/2
375
California, Colorado, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania
2019-05-14
Active, closed
InGeneron, Inc.
Not applicable
168
Arizona, California, Florida, Georgia, Louisiana, Michigan, North Dakota, South Dakota
2019-05-13
Recruiting
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
NCT03480971Mucositis, Nephrotoxicity, Ototoxicity
Matrix Biomed, Inc.
Phase 2
120
California, New York, North Carolina, Washington
2019-05-13
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Arkansas, California, Florida, Illinois, Indiana, Kentucky, Louisiana, Massachusetts
2019-05-09
Active, closed
Rakuten Medical, Inc.
Phase 3
135
Florida, Georgia, Kentucky, Pennsylvania, Texas
2019-05-09
Active, closed
Angiodynamics, Inc.
Observational
532
California, Florida, Georgia, Illinois, Iowa, Kentucky, Minnesota, Missouri
2019-05-08
Active, closed
Novo Nordisk A/S
Phase 3
1,500
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana
2019-05-08
Active, closed
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
NCT03891953Carcinoma, Non-Small-Cell Lung, Melanoma, Nasopharyngeal Carcinoma, Microsatellite Stable Colorectal Cancer
DrugSpartalizumab
Novartis Pharmaceuticals
Phase 1
98
Massachusetts, Tennessee
2019-05-07
Active, closed
Corvus Pharmaceuticals, Inc.
Phase 1
151
California, Michigan, Missouri, New Jersey, Ohio, Pennsylvania
2019-05-03
Active, closed
Assessment of Medherent Medication Management Device and Adherence Platform
NCT03775044Mental Health Disorder, Medication Adherence
Terrapin Pharmacy
Not applicable
150
Maryland
2019-05-01
Active, closed
Intralytix, Inc.
Phase 1/2
30
Maryland, New York
2019-05-01
Active, closed
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT03907527Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Carcinoma
Precigen, Inc
Phase 1
71
Maryland, Washington
2019-04-30
Active, closed
Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
NCT03478462Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor, DIPG
DrugCLR 131
Cellectar Biosciences, Inc.
Phase 1
30
California, New York, North Carolina, Ohio, Texas, Wisconsin
2019-04-30
Recruiting
Amgen
Phase 3
56
California, Colorado, Missouri, New York, Ohio, Oklahoma, Pennsylvania, Texas
2019-04-29
Active, closed
Cook MyoSite
Phase 3
96
Arizona, California, District of Columbia, Kansas, Michigan, New Mexico, New York, North Carolina
2019-04-23
Active, closed
Blueprint Medicines Corporation
Phase 2
251
Alabama, Arizona, California, Florida, Georgia, Illinois, Kansas, Massachusetts
2019-04-16
Active, closed
AstraZeneca
Phase 3
810
California, District of Columbia, Florida, Kansas, Kentucky, Massachusetts, Missouri, North Carolina
2019-04-16
Active, closed
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
NCT03907852Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura, Mesotheliomas Pleural
DrugsIpilimumab·Fludarabine·Nivolumab·Cyclophosphamide
TCR2 Therapeutics
Phase 1/2
57
California, Florida, Illinois, Maryland, New York, North Carolina, Pennsylvania, Tennessee
2019-04-15
Recruiting
Allarity Therapeutics
Phase 2
40
Oklahoma, Washington
2019-04-15
Recruiting
Allarity Therapeutics
Observational
60
Florida, Georgia, New Mexico, New York, Oklahoma, Texas, Washington
2019-04-11
Active, closed
Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors
NCT03647163Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma, Renal Cell Carcinoma (RCC)
DrugsVSV-IFNβ-NIS·Ipilimumab·Nivolumab·Pembrolizumab
Vyriad, Inc.
Phase 1/2
33
Minnesota, Ohio
2019-04-09
Recruiting
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
NCT03802695Acute Myeloid Leukemia, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia, Acute Lymphoblastic Leukemia
Orca Biosystems, Inc.
Phase 1
300
California, Florida, Georgia, Kansas, New Jersey, New York, Ohio, Texas
2019-04-08
Active, closed
Sun Pharmaceutical Industries, Inc.
Phase 2/3
1,000
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Idaho
2019-04-04
Active, closed
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
NCT03913143Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis, Vision Disorders
DrugSepofarsen
ProQR Therapeutics
Phase 2/3
36
Iowa
2019-04-04
Recruiting
AstraZeneca
Phase 3
140
Alabama, Georgia, Maryland, Michigan, Missouri, New Jersey, New York, North Carolina
2019-04-02
Recruiting
Lixte Biotechnology Holdings, Inc.
Phase 1/2
47
Florida
2019-04
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois
2019-03-28
Active, closed
Eisai Inc.
Phase 3
1,906
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Hawaii
2019-03-27
Active, closed
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
NCT03941379Choroidal Melanoma, Indeterminate Lesions of Eye
Aura Biosciences
Observational
63
Arizona, California, Massachusetts, Michigan, Minnesota, New York, Oregon, Pennsylvania
2019-03-27
Active, closed
AbbVie
Phase 3
964
Alabama, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Illinois
2019-03-25
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Arizona, Arkansas, California, Connecticut, Florida, Georgia, Maryland, Michigan
2019-03-22
Active, closed
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
NCT03860272Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases, Endometrial Cancer
DrugsBalstilimab·Botensilimab
Agenus Inc.
Phase 1
499
Arizona, California, Colorado, Connecticut, Florida, Massachusetts, New York, Oregon
2019-03-20
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
California, Florida, Georgia, Iowa, Kansas, Maine, Maryland, Massachusetts
2019-03-20
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2
20
California, Massachusetts
2019-03-20
Active, closed
Intra-operative Pancreatoscopy in Patients With IPMN
NCT03729453Intraductal Papillary Mucinous Neoplasm
Boston Scientific Corporation
Observational
100
Colorado, Indiana, Maryland
2019-03-20
Active, closed
AlloSource
Observational
34
Illinois, Kentucky, Ohio
2019-03-18
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
California, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Missouri
2019-03-15
Recruiting
Abbott Medical Devices
Observational
2,000
Arizona, California, Florida, Illinois, Indiana, Minnesota, Missouri, Nevada
2019-03-13
Recruiting
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
NCT03290534Lung Cancer, Lung Cancer Stage I, Lung Cancer Stage II
CivaTech Oncology
Phase 2
40
New York
2019-03-13
Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
NCT03664609Parkinson Disease, Essential Tremor, Dystonia
Boston Scientific Corporation
Observational
5,000
Arizona, California, Florida, Idaho, New York, North Carolina, Pennsylvania, Washington
2019-03-12
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Alabama, California, Connecticut, Florida, Georgia, Massachusetts, North Carolina, Ohio
2019-03-11
Recruiting
Imugene Limited
Phase 1
135
Florida, Georgia, Maryland, Massachusetts, Minnesota, New York, Rhode Island, Texas
2019-03-11
Active, closed
Troriluzole in Adult Participants With Spinocerebellar Ataxia
NCT03701399Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3
DrugTroriluzole
Biohaven Pharmaceuticals, Inc.
Phase 3
299
Arizona, California, Colorado, Florida, Georgia, Illinois, Maryland, Massachusetts
2019-03-08
Active, closed
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies
DrugDurvalumab
AstraZeneca
Phase 1/2
50
Maryland, Massachusetts, New York, Oklahoma, South Carolina
2019-03-07
Active, closed
AbbVie
Phase 3
444
Alabama, California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana
2019-03-07
Active, closed
AstraZeneca
Phase 3
724
Alabama, Arizona, California, Delaware, District of Columbia, Florida, Georgia, Illinois
2019-03-06
Recruiting
Two Dose Levels of Privigen in Pediatric CIDP
NCT03684018Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
CSL Behring
Phase 4
30
Arizona, California, Iowa, Ohio, Pennsylvania, Tennessee, Texas, Virginia
2019-02-28
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Colorado, Connecticut, Massachusetts, North Carolina, Pennsylvania, Texas
2019-02-28
Active, closed
Acerta Pharma BV
Phase 3
984
California, Indiana, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, New York
2019-02-25
Active, closed
The CONFORMAL Early Feasibility Study
NCT03616028Non-valvular Atrial Fibrillation
Conformal Medical, Inc
Not applicable
64
Arkansas, California, New Hampshire, New York, Ohio, Pennsylvania, Tennessee, Texas
2019-02-22
Active, closed
AbbVie
Phase 1
364
Arkansas, California, Connecticut, Florida, Indiana, Michigan, Missouri, Montana
2019-02-21
Recruiting
ProACT Post-Approval Study
NCT03767595Stress Urinary Incontinence
Uromedica
Not applicable
145
California, Colorado, Florida, Georgia, Kansas, Michigan, Minnesota, Nebraska
2019-02-19
Recruiting
RedDress Ltd.
Observational
500
Nevada
2019-02-14
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2019-02-08
Active, closed
Sernova Biotherapeutics Inc.
Phase 1/2
17
Illinois
2019-02-07
Active, closed
Clinical Trial Multi-analyte Blood Test
NCT03694600Liver Cirrhosis
Helio Genomics
Observational
1,900
Arizona, California, Colorado, Florida, Georgia, Illinois, Kansas, Kentucky
2019-02-04
Active, closed
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
NCT03732794Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
AtriCure, Inc.
Not applicable
150
California, District of Columbia, Illinois, Indiana, Maryland, Michigan, Minnesota, Missouri
2019-01-30
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Hawaii
2019-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Illinois
2019-01-25
Recruiting
Exactech
Observational
1,000
Colorado, Florida, Nevada, Ohio, South Carolina
2019-01-23
By invitation
The Informed Genetics Annotated Patient Registry
NCT04419896Predisposition, Genetic
Medneon
Observational
10,000
California, Illinois, Michigan, Tennessee, Texas
2019-01-23
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
387
Florida, Georgia, Indiana, Kentucky, Michigan, New Jersey, New York, Ohio
2019-01-23
Recruiting
Travere Therapeutics, Inc.
Phase 1/2
39
Colorado, Florida, Illinois, Indiana, Maine, Massachusetts, New York, North Carolina
2019-01-22
Active, closed
Study of NEO-201 in Solid Tumors Expansion Cohorts
NCT03476681Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer, Uterine Cancer
DrugPembrolizumab
Precision Biologics, Inc
Phase 1/2
121
Maryland, Virginia
2019-01-18
Active, closed
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
NCT03589339Radiotherapy, Immunotherapy, Microsatellite Instability-High Solid Malignant Tumour, Metastasis From Malignant Tumor of Liver
DrugsJNJ-90301900·Opdivo·Nivolumab·Keytruda
Nanobiotix
Phase 1
145
California, Florida, Georgia, Illinois, Maryland, Michigan, New Mexico, New York
2019-01-16
Active, closed
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
NCT03785249Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease
DrugsAdagrasib·Afatinib·Cetuximab·Pembrolizumab
Mirati Therapeutics Inc.
Phase 1/2
731
Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, Florida
2019-01-15
Active, closed
Kartos Therapeutics, Inc.
Phase 2
20
Alabama, California, Missouri, Ohio
2019-01-15
Recruiting
Persevere Therapeutics Inc.
Phase 1
18
Illinois, Kansas, Massachusetts, Pennsylvania
2019-01-14
Active, closed
AstraZeneca
Phase 2
367
California, District of Columbia, Maryland, Massachusetts, Minnesota, New York, Pennsylvania, Washington
2019-01-09
By invitation
Implementation of the NEDS EyeCTester App
NCT04607369Optic Nerve Disease, Macular Disease, Visual Pathway Disorder
Neuro-Eye Diagnostic Systems, LLC
Observational
100
Texas
2019-01-09
By invitation
Sarepta Therapeutics, Inc.
Observational
300
Arkansas, California, District of Columbia, Florida, Iowa, Kansas, Maryland, Missouri
2019-01-07
Recruiting
BioDelivery Sciences International
Observational
34,532
Delaware
2019-01-04
Active, closed
AstraZeneca
Phase 3
1,407
California, Florida, Georgia, Illinois, Indiana, Maryland, Michigan, Missouri
2019-01-04
Active, closed
9-ING-41 in Patients With Advanced Cancers
NCT03678883Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer
DrugsCCNU·Lomustine·Abraxane·Adriamycin
Actuate Therapeutics Inc.
Phase 2
350
Arizona, California, Delaware, District of Columbia, Florida, Illinois, Iowa, Kansas
2019-01-04
Active, closed
Celgene
Phase 3
363
California, Connecticut, District of Columbia, Florida, Kentucky, Maryland, Missouri, New Jersey
2019-01-02
Active, closed
Viewray Inc.
Not applicable
133
California, Florida, Massachusetts, Michigan, Missouri, New Hampshire, New York, Oregon
2019-01-01
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Alabama, Arizona, California, Colorado, Delaware, Florida, Georgia, Hawaii
2018-12-28
Active, closed
Surveillance HeartCare® Outcomes Registry
NCT03695601Heart Transplant Rejection
CareDx
Observational
2,743
Arizona, Arkansas, California, Connecticut, District of Columbia, Florida, Georgia, Illinois
2018-12-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana
2018-12-27
Active, closed
AstraZeneca
Phase 1
175
Iowa, Pennsylvania, Tennessee
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Alaska, Arizona, California, Colorado, Florida, Georgia, Illinois, Kansas
2018-12-24
Active, closed
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2
184
Arizona, California, Florida, Georgia, Kentucky, Louisiana, Minnesota, New Mexico
2018-12-21
Active, closed
AstraZeneca
Phase 2
401
Florida, Missouri, Pennsylvania, Tennessee, Texas
2018-12-21
Active, closed
AstraZeneca
Phase 1/2
243
Arizona, Maryland, Massachusetts, Michigan, Missouri, Texas, Virginia
2018-12-21
Active, closed
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
NCT03661866Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo
Target PharmaSolutions, Inc.
Observational
15,000
Arizona, Arkansas, California, District of Columbia, Florida, Illinois, Indiana, Kansas
2018-12-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
California, Colorado, District of Columbia, Florida, Idaho, Illinois, Kansas, Kentucky
2018-12-17
Active, closed
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260Hypertension, Vascular Diseases, Cardiovascular Diseases
ReCor Medical, Inc.
Not applicable
224
Alabama, California, Connecticut, District of Columbia, Florida, Georgia, Illinois, Louisiana
2018-12-14
Active, closed
Avenue Therapeutics, Inc.
Phase 3
360
California, Texas
2018-12-14
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Arizona, California, Colorado, Georgia, Kentucky, Maryland, Massachusetts, Michigan
2018-12-12
Active, closed
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
NCT03228667Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Urothelial Carcinoma, Head and Neck Squamous Cell Carcinoma
DrugsPD-L1 t-haNK·Avelumab·Atezolizumab·Durvalumab
ImmunityBio, Inc.
Phase 2
40
Alaska, Arkansas, California, Florida, Indiana, Iowa, Kentucky, Massachusetts
2018-12-11
Active, closed
TransMedics
Observational
458
Arizona, California, Florida, Georgia, Illinois, Maryland, Massachusetts, Michigan
2018-12-10
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia
2018-12-07
Recruiting
InGeneron, Inc.
Not applicable
40
Florida, South Dakota
2018-12-07
Active, closed
AstraZeneca
Phase 3
825
Arizona, California, Colorado, Florida, Illinois, Kansas, Kentucky, Maryland
2018-12-06
Active, closed
OBI Pharma, Inc
Phase 3
575
California, Florida, Illinois, Maryland, Michigan, New Jersey, Pennsylvania, Texas
2018-12-05
Active, closed
NOVOCART 3D Treatment Following Microfracture Failure
NCT03219307Articular Cartilage Defect
Aesculap Biologics, LLC
Phase 3
30
Illinois, Ohio, Utah
2018-11-30
Active, closed
AstraZeneca
Phase 3
724
California, District of Columbia, Florida, Hawaii, Illinois, Louisiana, Michigan, Minnesota
2018-11-30
Active, closed
TReatment of Pulmonary Hypertension Group II Study
NCT03611270Pulmonary Hypertension (PH) Due to Left Heart Disease
SoniVie Inc.
Not applicable
15
California, Massachusetts
2018-11-30
Active, closed
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
NCT03706833Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
Edwards Lifesciences
Not applicable
1,247
Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Indiana
2018-11-30
Recruiting
Celyad Oncology SA
Phase 1
49
Florida
2018-11-28
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
California, Kansas, Louisiana, New Mexico, New York, South Carolina, Texas, Utah
2018-11-28
Active, closed
Advanced Accelerator Applications
Observational
1,014
Arizona, Ohio, Oregon, Washington
2018-11-28
Active, closed
Eli Lilly and Company
Phase 2/3
393
Arizona, Arkansas, California, Colorado, Florida, Georgia, Indiana, Massachusetts
2018-11-26
Active, closed
Healing Osteoarthritic Joints in the Wrist With Adult ADRCs
NCT03503305Osteoarthritis of the Wrist
InGeneron, Inc.
Not applicable
40
South Dakota, Texas
2018-11-21
Active, closed
Svelte Medical Systems, Inc.
Not applicable
12
Arizona, Michigan
2018-11-21
Active, closed
AstraZeneca
Phase 3
1,063
Alabama, California, Connecticut, Illinois, Iowa, Kansas, Kentucky, Louisiana
2018-11-16
Recruiting
Medtronic Terminate AF Study
NCT03546374Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
Medtronic Cardiac Surgery
Not applicable
160
California, Connecticut, Indiana, Massachusetts, Michigan, Missouri, Ohio, Pennsylvania
2018-11-15
Active, closed
Gene Therapy for Children With CLN3 Batten Disease
NCT03770572CLN3, Batten Disease
Neela Therapeutics
Phase 1/2
7
Ohio
2018-11-13
Recruiting
Cytrellis Biosystems, Inc.
Not applicable
35
California, Colorado, Florida, New York, Tennessee, Texas
2018-11-12
Active, closed
Zynerba Pharmaceuticals, Inc.
Phase 2/3
476
Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Maryland
2018-11-09
Active, closed
Early Weight-Bearing After the Lapiplasty Procedure
NCT03740282Hallux Valgus, Bunion
Treace Medical Concepts, Inc.
Not applicable
183
Colorado, Iowa, Missouri, Nevada, Pennsylvania, Texas
2018-11-06
Active, closed
Biojiva LLC
Phase 2/3
19
California, New Jersey
2018-11-05
Active, closed
Destination Therapy Post Approval Study
NCT03681210Chronic Heart Failure
Medtronic Cardiac Rhythm and Heart Failure
Observational
300
Arkansas, California, Colorado, Florida, Illinois, Indiana, Kansas, Kentucky
2018-10-31
Active, closed
AstraZeneca
Phase 3
895
Alabama, Alaska, Arizona, California, Colorado, Illinois, Indiana, Louisiana
2018-10-31
Active, closed
Medtronic Cardiovascular
Not applicable
150
Arizona, California, Connecticut, Florida, Georgia, Iowa, Massachusetts, Michigan
2018-10-30
Active, closed
Kolon TissueGene, Inc.
Phase 3
535
Alabama, Arizona, California, District of Columbia, Florida, Georgia, Illinois, Louisiana
2018-10-30
Active, closed
Janssen Research & Development, LLC
Phase 3
84
California, Colorado, Connecticut, Delaware, Georgia, Minnesota, New York, Tennessee
2018-10-29
Active, closed
Poseida Therapeutics, Inc.
Phase 1
100
California, Colorado, Illinois, Kansas, Maryland, Michigan, Pennsylvania, Tennessee
2018-10-29
Recruiting
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
NCT03588975Chondral Defect, Osteochondritis Dissecans (OCD), Articular Cartilage Defect, Articular Cartilage Disorder of Knee
Vericel Corporation
Phase 3
45
California, Louisiana, Maryland, Michigan, New York, Ohio, Pennsylvania, Rhode Island
2018-10-24
Active, closed
AbbVie
Phase 3
265
Arizona, California, Colorado, Florida, Kentucky, Maryland, Massachusetts, Michigan
2018-10-22
Active, closed
Tesaro, Inc.
Phase 3
1,400
Alaska, Arizona, California, Connecticut, Florida, Illinois, Louisiana, Maine
2018-10-11
Active, closed
AstraZeneca
Phase 1
396
Colorado, Florida, Pennsylvania, Tennessee, Utah
2018-10-11
Active, closed
AbbVie
Phase 2
270
Alabama, Arizona, Arkansas, California, Colorado, Florida, Hawaii, Illinois
2018-10-10
Recruiting
Inhibrx Biosciences, Inc
Phase 1
411
Arizona, California, Colorado, Georgia, Illinois, Michigan, New York, Ohio
2018-10-08
Active, closed
Exelixis
Phase 3
187
California, Colorado, Connecticut, District of Columbia, Florida, Illinois, Kentucky, Massachusetts
2018-10-05
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Methotrexate
Takeda
Phase 3
245
Alabama, California, Georgia, Indiana, Kansas, Maryland, New Jersey, New York
2018-10-04
Active, closed
Hollister Incorporated
Observational
5,000
Illinois
2018-10-04
Recruiting
InSightec
Not applicable
50
Florida, New York, Ohio, Texas, West Virginia
2018-09-28
By invitation
The Influence of Repairing the Sub-scapularis on Outcomes After Reverse Arthroplasty
NCT03711175Severe Arthropathy With a Grossly Deficient Rotator Cuff
Encore Medical, L.P.
Not applicable
200
Missouri, New York, Pennsylvania, Texas
2018-09-28
Active, closed
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)
NCT03566043Mucopolysaccharidosis Type II (MPS II)
REGENXBIO Inc.
Phase 2/3
48
California, New Jersey, Pennsylvania
2018-09-27
Active, closed
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
NCT03634540Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC), Kidney Cancer, Renal Cancer
DrugsBelzutifan·Cabozantinib
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
118
California, Florida, Massachusetts, Michigan, Tennessee, Texas, Washington
2018-09-27
Active, closed
AstraZeneca
Phase 3
730
Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky
2018-09-27
Recruiting
Vanda Pharmaceuticals
Phase 1
42
District of Columbia, Indiana, New Jersey, Washington
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Alabama, California, Connecticut, District of Columbia, Florida, Illinois, Indiana, Kansas
2018-09-27
Active, closed
GenSight Biologics
Phase 1/2
10
Pennsylvania
2018-09-26
Active, closed
Biofrontera Inc.
Phase 3
187
Arizona, California, Colorado, Florida, Indiana, Michigan, New Hampshire, New York
2018-09-25
Active, closed
Hoffmann-La Roche
Phase 1/2
422
Alabama, California, Colorado, Florida, Michigan, New York, North Carolina, Pennsylvania
2018-09-25
Recruiting
Novartis Pharmaceuticals
Observational
700
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Indiana, Iowa
2018-09-25
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
DrugDaromun
Philogen S.p.A.
Phase 3
186
Arizona, California, Florida, Georgia, Illinois, Iowa, Minnesota, New Jersey
2018-09-20
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Iowa
2018-09-20
Active, closed
V-Wave Ltd
Not applicable
605
Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky, Minnesota
2018-09-19
Active, closed
Edwards Lifesciences
Not applicable
101
California, Colorado, District of Columbia, Florida, Georgia, Indiana, Kansas, Massachusetts
2018-09-18
Active, closed
CynosureLutronic
Not applicable
41
Massachusetts
2018-09-13
Recruiting
Cytrellis Biosystems, Inc.
Not applicable
30
Florida
2018-09-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Iowa
2018-09-12
Active, closed
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
NCT03393884Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
DrugsIMNN-001·Paclitaxel·Carboplatin
Imunon
Phase 1/2
130
Alabama, California, Florida, Massachusetts, Missouri, New Jersey, New York, Oklahoma
2018-09-05
Active, closed
Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency
NCT03636438Ornithine Transcarbamylase (OTC) Deficiency
Ultragenyx Pharmaceutical Inc
Observational
11
Colorado, Massachusetts, New York, Ohio
2018-08-30
Active, closed
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
NCT03611868Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma, P53 Mutation
DrugPembrolizumab
Ascentage Pharma Group Inc.
Phase 1/2
230
Arizona, Arkansas, California, District of Columbia, Florida, Missouri, New York, North Carolina
2018-08-29
Active, closed
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
NCT03726554Arthropathy of Shoulder Region, Grossly Deficient Rotator Cuff, Osteoarthritis of the Shoulder, Rheumatoid Arthritis Without Humeral Metaphyseal Defects
Zimmer Biomet
Not applicable
99
Florida, Kentucky, Michigan, New York, Tennessee, Virginia
2018-08-28
Active, closed
AbbVie
Phase 3
1,242
California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas
2018-08-28
Active, closed
Neurotechnology Following Traumatic Brain Injury
NCT03649958Post-Concussion Symptoms, Insomnia, Pain, Chronic, Depressive Symptoms
Brain State Technologies, LLC
Not applicable
80
Maryland, North Carolina
2018-08-28
Active, closed
Xynomic Pharmaceuticals, Inc.
Phase 2
139
Illinois, Kentucky, New York, Pennsylvania, Texas, Washington
2018-08-27
Active, closed
Smith & Nephew, Inc.
Observational
126
Minnesota, Nevada, South Carolina, Tennessee
2018-08-26
Active, closed
Ancora Heart, Inc.
Not applicable
22
California, Georgia, Kentucky, Louisiana, Minnesota, Nebraska, New Jersey, New York
2018-08-23
Active, closed
Sebela Women's Health Inc.
Phase 3
1,620
Arizona, California, Colorado, Florida, Georgia, Idaho, Indiana, Louisiana
2018-08-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Hawaii
2018-08-21
By invitation
Advanced Materials Science in XLIF Study
NCT03649490Degenerative Disc Disease, Spondylolisthesis
NuVasive
Observational
300
Connecticut, Florida, Illinois, Kentucky, Maryland, Minnesota, Missouri, North Carolina
2018-08-19
Active, closed
Hoffmann-La Roche
Phase 3
257
Illinois, Massachusetts, Pennsylvania
2018-08-16
Active, closed
Daiichi Sankyo
Phase 1/2
65
California, Colorado, Delaware, District of Columbia, Georgia, Minnesota, Ohio, Pennsylvania
2018-08-15
Active, closed
Spark Therapeutics, Inc.
Observational
29
Massachusetts, Mississippi, Missouri, Oregon, Pennsylvania, Virginia
2018-08-14
Recruiting
AMAG Pharmaceuticals, Inc.
Phase 3
129
Florida, Michigan, Missouri, New York, Ohio, West Virginia
2018-08-13
Active, closed
Gilead Sciences
Phase 2
502
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Kentucky
2018-08-13
Active, closed
AbbVie
Phase 3
1,533
Alabama, Arizona, California, Colorado, Connecticut, Florida, Idaho, Illinois
2018-08-09
Active, closed
C. R. Bard
Not applicable
213
Alabama, California, Connecticut, Iowa, Kentucky, Louisiana, Maryland, Massachusetts
2018-08-07
By invitation
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
NCT03628612Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL, ALL, Adult and Pediatric
Autolus Limited
Phase 2
500
Florida, Missouri, Texas
2018-08-02
Recruiting
Edwards Lifesciences
Not applicable
90
California, Colorado, Florida, Indiana, Kansas, Minnesota, New Jersey, New York
2018-07-31
Active, closed
SetPoint Medical Corporation
Not applicable
14
Florida, New York, Pennsylvania
2018-07-28
Active, closed
Actelion
Phase 2
63
Colorado, Iowa, Washington
2018-07-23
Recruiting
Viome
Observational
20,000
Washington
2018-07-23
Recruiting
Celgene
Phase 2/3
1,541
Alabama, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia
2018-07-19
Active, closed
AstraZeneca
Phase 3
216
California, Georgia, New Jersey, Utah, Wisconsin
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Alabama, Arizona, California, Florida, Georgia, Idaho, Illinois, Indiana
2018-07-18
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Arizona, California, Kentucky, Louisiana, Nebraska, New York, Ohio, Oregon
2018-07-17
Active, closed
X-linked Hypophosphatemia Disease Monitoring Program
NCT03651505X-linked Hypophosphatemia, Hypophosphatemic Rickets
Ultragenyx Pharmaceutical Inc
Observational
782
Alabama, California, Colorado, Connecticut, Illinois, Indiana, Maryland, Massachusetts
2018-07-16
Active, closed
SightGlass Vision, Inc.
Not applicable
266
California, Florida, Kansas, Louisiana, Missouri, New York, South Dakota, Tennessee
2018-07-16
Recruiting
Astellas Institute for Regenerative Medicine
Phase 1
42
Arizona, California, Florida, Georgia, Illinois, Massachusetts, Michigan, Mississippi
2018-07-13
Active, closed
Janssen Research & Development, LLC
Phase 3
120
California, Georgia, Illinois, New Jersey, New York, Ohio, Texas
2018-07-11
Recruiting
Jina Pharmaceuticals Inc.
Phase 3
657
Georgia, Missouri, Ohio
2018-07-10
Active, closed
ERG Components in Schizophrenia and Bipolar Disorder Type I
NCT03788811Schizophrenia, Bipolar I Disorder
diaMentis Inc.
Observational
300
California, Florida, Massachusetts, New Jersey, New York, Texas
2018-07-05
Active, closed
Edwards Lifesciences
Not applicable
75
Illinois, Minnesota, New Jersey, New York, Oregon, Pennsylvania, Texas, Utah
2018-07-01
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
NCT03505320Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin
DrugsFolinic acid·Zolbetuximab·Fluorouracil·Leucovorin
Astellas Pharma Global Development, Inc.
Phase 2
143
California, Illinois, Massachusetts, New York
2018-06-29
Recruiting
AtriCure, Inc.
Observational
5,000
Florida, Maryland, Missouri, New Hampshire, Ohio, Texas
2018-06-29
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Arizona, California, Colorado, Florida, Iowa, Louisiana, Michigan, Nebraska
2018-06-26
Active, closed
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck
DrugsTisotumab Vedotin·Tivdak·Keytruda·Cisplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
350
California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas
2018-06-25
Active, closed
Urotronic Inc.
Not applicable
127
Arizona, Arkansas, Florida, Iowa, Maryland, Minnesota, Nebraska, New Jersey
2018-06-22
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsFolinic acid·Zolbetuximab·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Kentucky
2018-06-21
Active, closed
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
NCT03626038Osteoarthritis, Rheumatoid Arthritis, Post-Traumatic Arthritis, Psoriatic Arthritis
Zimmer Biomet
Not applicable
135
Florida
2018-06-19
Active, closed
Abbott Medical Devices
Not applicable
103
Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho
2018-06-15
Active, closed
Lineage Cell Therapeutics, Inc.
Observational
25
California, Georgia, Illinois, Pennsylvania, Wisconsin
2018-06-13
Active, closed
Exelixis
Phase 3
837
Arizona, California, District of Columbia, Florida, Georgia, Illinois, Maryland, Massachusetts
2018-06-10
Recruiting
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
NCT03556228Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer, Non-Small Cell Lung Cancer
VM Oncology, LLC
Phase 1/2
242
California, Connecticut, District of Columbia, Florida, New Jersey, New Mexico, New York, Pennsylvania
2018-06-08
Active, closed
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
NCT03441971Heart Defects, Congenital, Tetralogy of Fallot, Pulmonary Valve Insufficiency, Pulmonary Valve Stenosis
W.L.Gore & Associates
Not applicable
15
Illinois, Massachusetts, Ohio
2018-06-07
Active, closed
Genentech, Inc.
Phase 1
123
Connecticut, Michigan, New York, Tennessee, Texas
2018-06-06
Recruiting
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
NCT05407207Diabetes Mellitus, Hemodialysis Complication, Cardiovascular Complication, Quality of Life
Hamad Medical Corporation
Not applicable
100
Texas
2018-06-01
Active, closed
Inovio Pharmaceuticals
Phase 1/2
52
California, Florida, Georgia, Massachusetts, Michigan, New Jersey, New York, North Carolina
2018-05-31
Active, closed
Hoffmann-La Roche
Phase 3
927
California, Florida, Illinois, Massachusetts, Michigan, Missouri, New York, Ohio
2018-05-28
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Alabama, Massachusetts, Minnesota, New York, Ohio, Oklahoma, Tennessee, Texas
2018-05-21
Recruiting
BioInvent International AB
Phase 1/2
140
Georgia, Kentucky
2018-05-16
Active, closed
pharmaand GmbH
Phase 3
1,097
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana
2018-05-14
Active, closed
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
NCT03444844Prostate Cancer Recurrent, Prostate Cancer
Five Eleven Pharma, Inc.
Phase 1/2
60
Indiana
2018-05-10
Active, closed
MedImmune LLC
Phase 1/2
43
California, Colorado, Connecticut, Georgia, Illinois, Maryland, New York, Texas
2018-05-08
Active, closed
Corcept Therapeutics
Phase 2
125
Arizona, California, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland
2018-05-07
By invitation
Smith & Nephew, Inc.
Observational
220
California, New York
2018-05-07
Active, closed
GlaxoSmithKline
Phase 2
237
Arizona, California, Colorado, Florida, Georgia, Maryland, Massachusetts, Minnesota
2018-05-03
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
DrugPetosemtamab
Genmab
Phase 1/2
560
California, Colorado, Florida, Georgia, Massachusetts, Michigan, Missouri, New York
2018-05-02
Active, closed
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
50
Maryland, Massachusetts, Michigan, Pennsylvania, Tennessee, Texas, Utah
2018-05-02
Recruiting
All4Cure
Observational
5,000
Washington
2018-04-26
Active, closed
Rna Diagnostics Inc.
Not applicable
801
Missouri
2018-04-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Arizona, California, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana
2018-04-24
Active, closed
CeraPedics, Inc
Not applicable
290
Alabama, California, Colorado, Connecticut, Florida, Illinois, Indiana, Kentucky
2018-04-24
Active, closed
MedImmune LLC
Phase 1
400
Michigan, New York, North Carolina, Rhode Island, Tennessee, Virginia
2018-04-24
Active, closed
Multi-Center Study of Sensory Stimulation to Improve Brain Function
NCT03556280Alzheimer Disease, Cognitive Impairment, Mild Cognitive Impairment, Dementia Alzheimers
Cognito Therapeutics, Inc.
Not applicable
60
Florida, Massachusetts, New Jersey
2018-04-24
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Arizona, Arkansas, California, Georgia, Massachusetts, Michigan, North Carolina, Pennsylvania
2018-04-23
Active, closed
JenaValve Technology, Inc.
Not applicable
100
California, District of Columbia, Georgia, Michigan, New York, Texas, Washington
2018-04-20
Active, closed
Bristol-Myers Squibb
Phase 3
545
Alabama, Arizona, California, Colorado, Florida, Georgia, Kansas, Louisiana
2018-04-18
Active, closed
The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration
NCT03348995Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture
Miach Orthopaedics
Not applicable
250
California, Florida, Georgia, Louisiana, Maryland, Massachusetts, New Jersey, Rhode Island
2018-04-17
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
DrugsMevrometostat·Xtandi·Itraconazole·Enzalutamide
Pfizer
Phase 1
453
Arizona, California, Connecticut, Kansas, Kentucky, Maryland, Massachusetts, Nebraska
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Kentucky, New Jersey, North Carolina
2018-04-17
Active, closed
Beacon Therapeutics
Phase 1/2
29
North Carolina, Ohio, Oregon, Texas
2018-04-16
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana
2018-04-13
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Arizona, California, District of Columbia, Florida, Georgia, Illinois, Indiana, Maryland
2018-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida
2018-04-09
By invitation
USWM CT, LLC
Phase 1
250
Georgia, Maryland, Michigan, Missouri, New York, North Carolina, Oregon, Pennsylvania
2018-04-09
Active, closed
AbbVie
Phase 3
1,336
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois
2018-04-09
Active, closed
Motiva USA LLC
Not applicable
800
California, Colorado, Georgia, Illinois, Indiana, Kentucky, Louisiana, Michigan
2018-04-06
Active, closed
Regeneron Pharmaceuticals
Observational
858
Alabama, Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana
2018-04-06
Recruiting
ClearNote Health
Observational
20,000
California
2018-04-05
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Colorado, Kentucky, Maryland, New Jersey, New York, North Carolina, Ohio, Pennsylvania
2018-04-05
Active, closed
Y-mAbs Therapeutics
Phase 2
122
Indiana, New York
2018-04-03
Active, closed
AbbVie
Phase 2
156
Colorado, Florida, Georgia, Illinois, Massachusetts, New Jersey, New York, North Carolina
2018-04-02
Recruiting
Hoffmann-La Roche
Phase 1/2
1,132
California, Colorado, Florida, Illinois, Minnesota, Nebraska, Nevada, New Jersey
2018-03-30
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Alaska, California, District of Columbia, Florida, Georgia, Illinois, Kentucky, Maryland
2018-03-23
Active, closed
BioLineRx, Ltd.
Phase 3
180
California, Florida, Illinois, Maryland, Minnesota, Missouri, Ohio, Texas
2018-03-23
Recruiting
Regenexx, LLC
Not applicable
80
Colorado
2018-03-23
Active, closed
Fujifilm Pharmaceuticals U.S.A., Inc.
Phase 1
90
Arizona, California, Colorado, Tennessee, Texas, Washington
2018-03-22
Active, closed
AbbVie
Phase 3
747
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Idaho
2018-03-21
Active, closed
Orion Corporation, Orion Pharma
Phase 1/2
204
Maryland, Minnesota, Nebraska, New York
2018-03-19
By invitation
Compliant Analysis of Patient Samples and Data
NCT04364503Pregnancy Related, Cancer, Infectious Disease
Sequenom, Inc.
Observational
2,000
California, Colorado, Illinois, New York, North Carolina
2018-03-17
Active, closed
AstraZeneca
Phase 2
154
Alabama, Arizona, Florida, Kentucky, New York, Pennsylvania, Tennessee, Washington
2018-03-16
Active, closed
Eli Lilly and Company
Phase 3
533
Alabama, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois
2018-03-14
Active, closed
RenovoRx
Phase 3
190
California, District of Columbia, Florida, Iowa, Maryland, Nebraska, New Hampshire, New Jersey
2018-03-12
Active, closed
AstraZeneca
Phase 2
273
Alabama, Alaska, Arizona, Colorado, Connecticut, Illinois, Indiana, Kentucky
2018-03-07
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Arizona, Colorado, Florida, Indiana, Maryland, Michigan, New York, Pennsylvania
2018-03-02
Recruiting
bioAffinity Technologies Inc.
Observational
500
New Jersey, New Mexico, Texas
2018-03-01
Active, closed
PRospective Multiple Myeloma Impact Study
NCT02911571Multiple Myeloma
SkylineDx
Not applicable
250
District of Columbia, Georgia, New Jersey, New York, North Carolina, Wisconsin
2018-02-27
Recruiting
The PREDICT Registry:
NCT03448926DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
PreludeDx
Observational
3,000
Arizona, California, Colorado, Florida, Georgia, Illinois, Maryland, Massachusetts
2018-02-27
Recruiting
Octapharma
Observational
200
Florida, Louisiana, Missouri, Nevada, Texas
2018-02-13
Active, closed
InSightec
Not applicable
92
California, Florida, Maryland, Massachusetts, Minnesota, New York, Ohio, Pennsylvania
2018-02-09
Active, closed
CynosureLutronic
Not applicable
10
New York
2018-02-07
Active, closed
PARTNER 3 Trial - Mitral Valve in Valve
NCT03193801Mitral Valve Insufficiency, Mitral Valve Disease, Mitral Valve Regurgitation, Heart Failure
Edwards Lifesciences
Not applicable
53
Georgia, Illinois, Massachusetts, Minnesota, Missouri, New York, Oregon, Texas
2018-02-01
Active, closed
AMPLATZER PFO Occluder Post Approval Study
NCT03309332Stroke, Patent Foramen Ovale
Abbott Medical Devices
Not applicable
1,214
Alabama, Arizona, Arkansas, California, Colorado, District of Columbia, Florida, Georgia
2018-01-31
Active, closed
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
NCT03401385Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer, Non-small Cell Lung Cancer
DrugDato-DXd
Daiichi Sankyo Co., Ltd.
Phase 1
890
California, District of Columbia, Georgia, Maryland, Massachusetts, New York, Tennessee, Texas
2018-01-31
Recruiting
Mucopolysaccharidosis VII Disease Monitoring Program
NCT03604835Mucopolysaccharidosis VII, MPS VII, MPS 7, Sly Syndrome
Ultragenyx Pharmaceutical Inc
Observational
50
California, District of Columbia, Illinois, Michigan, New York, Utah, Washington
2018-01-29
Recruiting
Dabrafenib and/or Trametinib Rollover Study
NCT03340506Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
100
Arizona, Maryland, Ohio, Texas
2018-01-26
Active, closed
EBR Systems, Inc.
Not applicable
300
Alabama, California, Florida, Georgia, Illinois, Indiana, Iowa, Kansas
2018-01-17
By invitation
Astellas Institute for Regenerative Medicine
Phase 1/2
36
Missouri
2018-01-08
Active, closed
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
DrugIMGN632
AbbVie
Phase 1/2
179
Alabama, Arizona, California, Florida, Maryland, Massachusetts, New York, North Carolina
2018-01-02
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Indiana
2018-01-01
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
NCT03452774Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver
Massive Bio, Inc.
Observational
50,000
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida
2018-01-01
Recruiting
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
NCT03657745Alzheimer Disease, Mild Cognitive Impairment, Dementia, Cognition Disorders in Old Age
Alzheimer's Light LLC
Observational
2,000
Florida
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
California, Connecticut, District of Columbia, Florida, Georgia, Illinois, Maryland, Massachusetts
2017-12-29
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma
DrugsEmavusertib·Ibrutinib
Curis, Inc.
Phase 1/2
152
Arizona, California, Connecticut, Florida, Illinois, Massachusetts, Minnesota, Nebraska
2017-12-28
Active, closed
Amgen
Phase 1
269
California, Connecticut, Florida, Georgia, Illinois, Louisiana, Maryland, Michigan
2017-12-26
Active, closed
W.L.Gore & Associates
Not applicable
175
Alabama, Arizona, California, Florida, Georgia, Illinois, Iowa, Louisiana
2017-12-19
Active, closed
AstraZeneca
Phase 2
528
California, District of Columbia, Illinois, Maryland, Massachusetts, Missouri, New York, Pennsylvania
2017-12-18
Active, closed
Pfizer
Phase 3
1,054
Alaska, Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana
2017-12-18
Active, closed
Janssen Research & Development, LLC
Phase 1
279
Alabama, California, Colorado, New York, Tennessee
2017-12-16
Active, closed
Bolton Medical
Not applicable
56
California, Colorado, Connecticut, District of Columbia, Georgia, Illinois, Indiana, Iowa
2017-12-14
Active, closed
BioMarin Pharmaceutical
Phase 3
119
California, Delaware, Georgia, Illinois, Maryland, Missouri, Ohio, Texas
2017-12-12
Active, closed
Gilead Sciences
Phase 3
340
Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana
2017-12-12
Active, closed
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b
NCT03319628Platinum Resistant Ovarian Cancer, Non Small Cell Lung Cancer Metastatic
Mersana Therapeutics
Phase 1/2
523
Oklahoma
2017-12-12
Active, closed
Sanofi
Phase 3
475
Florida, Missouri, Tennessee, Texas
2017-12-07
Active, closed
Solid Biosciences Inc.
Phase 1/2
12
California, Florida
2017-12-06
Active, closed
Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System
NCT03214601Thoracic Aorta Aneurysm, Aneurysm, Ruptured, Aortic Aneurysm
Bolton Medical
Not applicable
30
California, Florida, Georgia, Maryland, Massachusetts, Missouri, New York, North Carolina
2017-12-04
Active, closed
US Oncology Research
Phase 1/2
34
Texas
2017-11-29
Active, closed
Juno Therapeutics, a Subsidiary of Celgene
Phase 1/2
320
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois
2017-11-27
Active, closed
Genentech, Inc.
Phase 1
181
Colorado, Massachusetts, New York, Tennessee
2017-11-24
Active, closed
Second Sight Medical Products
Not applicable
6
California, Texas
2017-11-20
Active, closed
Restorbio Inc.
Phase 2
652
Kansas
2017-11-15
By invitation
Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty
NCT06203756Arthroplasties, Knee Replacement, Revision Arthroplasty
Corin
Not applicable
713
Arizona, Connecticut, Michigan, New York, Oklahoma, Wisconsin
2017-11-09
Active, closed
BeiGene
Phase 3
590
Georgia, Illinois, Massachusetts, Missouri, Nevada, New Jersey, New York, North Carolina
2017-10-31
Active, closed
Daiichi Sankyo
Phase 1
312
California, Georgia, Massachusetts, Michigan, New York, Ohio, Pennsylvania, Tennessee
2017-10-30
Active, closed
ViiV Healthcare
Phase 3
1,049
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois
2017-10-27
Recruiting
Italfarmaco
Phase 2/3
206
California, Connecticut, Florida, Georgia, Iowa, Missouri, Oregon, Pennsylvania
2017-10-24
Recruiting
Medtronic Cardiovascular
Not applicable
1,056
Alabama, Arizona, California, Connecticut, District of Columbia, Florida, Georgia, Illinois
2017-10-23
Active, closed
Genzyme, a Sanofi Company
Phase 2
22
New York, North Carolina, Washington
2017-10-12
Active, closed
AstraZeneca
Phase 3
1,324
California, District of Columbia, Florida, Kansas, Maryland, Michigan, Minnesota, New York
2017-10-11
By invitation
Collection of Anonymized Samples
NCT03319446Healthy, Respiratory Disease, Gastrointestinal Disease
BioFire Diagnostics, LLC
Observational
1,500
Utah
2017-10-09
Active, closed
Performance of MOTO Medial® Unicompartmental Knee Arthroplasty
NCT03211663Knee Osteoarthritis, Knee Arthritis, Knee Pain Chronic
Medacta USA
Observational
269
Florida, Kentucky, Montana, North Carolina, Pennsylvania
2017-10-09
Recruiting
Apollomics Inc.
Phase 2
497
California, Florida, Massachusetts, North Carolina, Pennsylvania, Wisconsin
2017-09-27
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
California, Colorado, Florida, Kentucky, Nevada, New Hampshire, New York, Oregon
2017-09-22
Active, closed
Novartis Gene Therapies
Observational
13
Ohio
2017-09-21
Active, closed
Hoffmann-La Roche
Phase 3
382
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2017-09-20
Active, closed
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
DrugsVusolimogene Oderparepvec·Opdivo·Nivolumab
Replimune, Inc.
Phase 2
340
Alabama, Arizona, Arkansas, California, Florida, Iowa, Kentucky, Minnesota
2017-09-20
Active, closed
DePuy Orthopaedics
Not applicable
400
California, Colorado, Connecticut, Florida, Kentucky, Mississippi, New Hampshire, New Jersey
2017-09-19
Active, closed
Takeda
Phase 1/2
59
Colorado, Ohio
2017-09-06
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2017-09-05
Active, closed
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
NCT03260023HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma
DrugAvelumab
Transgene
Phase 1/2
143
Florida, Minnesota
2017-09-01
Active, closed
BioVentrix Revivent TC™ System Clinical Study
NCT02931240Ventricular Dysfunction, Left
BioVentrix
Not applicable
126
Arizona, California, Florida, Georgia, Illinois, Louisiana, Michigan, Minnesota
2017-08-29
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Arizona, California, Colorado, Connecticut, Illinois, Minnesota, New Jersey, Ohio
2017-08-23
Active, closed
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
NCT03130777Pulmonary Disease, Transcatheter Pulmonary Valve Replacement (TPVR), Tetralogy of Fallot, Congenital Heart Disease
Edwards Lifesciences
Not applicable
86
California, Colorado, Georgia, Missouri, New York, Ohio, Pennsylvania, Texas
2017-08-22
Active, closed
Medtronic
Observational
1,092
Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia
2017-08-21
Recruiting
Advenchen Laboratories, LLC
Phase 3
325
Arizona, California, Colorado, Florida, Illinois, Michigan, Minnesota, Missouri
2017-08-15
Active, closed
ModernaTX, Inc.
Phase 1
161
California, District of Columbia, Florida, Massachusetts, New York, Ohio, Pennsylvania, Texas
2017-08-14
Active, closed
Astellas Gene Therapies
Phase 2/3
27
California, Illinois, Maryland
2017-08-02
Active, closed
Neonc Technologies, Inc.
Phase 1/2
49
California, Georgia, Louisiana, New Jersey, New York, North Carolina, Ohio, Texas
2017-08-01
Active, closed
JOURNEY II XR Safety and Effectiveness PMCF
NCT03136887Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee, Unilateral Post-Traumatic Osteoarthritis of Knee, Knee Osteoarthritis, Degenerative Arthritis Peripheral Joint
Smith & Nephew, Inc.
Observational
176
California, Florida, Illinois, Maryland, Michigan, Nevada, New Jersey, New York
2017-07-28
Active, closed
Eisai Inc.
Phase 1
60
Arizona, California, Florida, Minnesota, Texas
2017-07-27
Active, closed
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
NCT02952508Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugCLR 131
Cellectar Biosciences, Inc.
Phase 2
120
California, District of Columbia, Florida, Georgia, Illinois, Kansas, Louisiana, Maryland
2017-07-26
Active, closed
The Chocolate Touch Study
NCT02924857Peripheral Artery Disease (PAD), Ischemia, Intermittent Claudication
TriReme Medical, LLC
Not applicable
333
Florida, Georgia, Louisiana, Michigan, Mississippi, Missouri, New York, Ohio
2017-07-26
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
DrugsSavolitinib·Sunitinib
AstraZeneca
Phase 3
60
California, Georgia, Illinois, Iowa, Massachusetts, Missouri, New York, Tennessee
2017-07-25
By invitation
Bausch Health Americas, Inc.
Observational
3,500
New Jersey
2017-07-25
Active, closed
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
NCT03251118Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis
Target PharmaSolutions, Inc.
Observational
15,000
California, Colorado, Florida, Georgia, Illinois, Indiana, Iowa, Louisiana
2017-07-24
Active, closed
United Therapeutics
Observational
300
California, Colorado, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky
2017-07-18
Active, closed
LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis
NCT03115983Degenerative Spondylolisthesis, Lumbar Spinal Stenosis
Empirical Spine, Inc.
Not applicable
299
Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Kentucky
2017-07-17
Active, closed
Eli Lilly and Company
Phase 3
5,637
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida
2017-07-12
Active, closed
Edwards Lifesciences
Not applicable
901
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2017-07-12
Active, closed
The REPLACE Registry for Cholbam® (Cholic Acid)
NCT03115086Bile Acid Synthesis Disorders
Mirum Pharmaceuticals, Inc.
Observational
55
Alabama, California, Florida, Georgia, Indiana, Louisiana, Minnesota, Missouri
2017-07-10
Active, closed
Novartis Pharmaceuticals
Phase 2
29
Massachusetts
2017-07-04
Recruiting
Combination of TATE and PD-1 Inhibitor in Liver Cancer
NCT03259867Hepatocellular Carcinoma, Gastric Cancer
DrugOpdivo
Teclison Ltd.
Phase 2
54
California, Oklahoma, Wisconsin
2017-07-01
Active, closed
Medtronic Spinal and Biologics
Not applicable
100
California, Colorado, Florida, Georgia, Indiana, Kansas, Michigan, New York
2017-06-29
Active, closed
Hoffmann-La Roche
Phase 2
316
Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Kansas
2017-06-27
Active, closed
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)
NCT03162536Lymphoma, B-Cell, Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia
DrugNemtabrutinib
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1/2
190
Arizona, California, Colorado, Michigan, Minnesota, North Carolina, Ohio, Tennessee
2017-06-26
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Alabama, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Illinois
2017-06-26
Active, closed
Cellectis S.A.
Phase 1
29
California, Florida, Illinois, Massachusetts, New York, Pennsylvania, Texas
2017-06-19
Recruiting
CardioFocus HeartLight Post-Approval Study
NCT03168659Atrial Fibrillation
CardioFocus
Not applicable
250
Arizona, Illinois, New York, Virginia
2017-06-16
Active, closed
ImmunityBio, Inc.
Phase 2/3
190
Alaska, Arkansas, California, Colorado, Florida, Georgia, Hawaii, Illinois
2017-06-02
Active, closed
AstraZeneca
Phase 3
1,186
Arizona, California, Florida, Kentucky, Missouri, Ohio, Pennsylvania, Tennessee
2017-06-01
Recruiting
CivaTech Oncology
Phase 1/2
80
Florida, Illinois, Louisiana, Pennsylvania, Virginia
2017-05-31
Active, closed
DePuy Orthopaedics
Not applicable
400
California, Colorado, Connecticut, Florida, Kentucky, Mississippi, Missouri, New Hampshire
2017-05-30
Recruiting
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
NCT02926690Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer
OncoTherapy Science, Inc.
Phase 1
70
Connecticut, Georgia, Hawaii, New Hampshire, New York, Texas, Wisconsin
2017-05-29
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
California, Georgia, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Jersey
2017-05-22
Active, closed
Global Kinetics Corporation
Not applicable
231
California, Florida, Kansas, Maryland, Michigan, New York, Texas
2017-05-17
Active, closed
Janssen Research & Development, LLC
Phase 1
302
California, Colorado, New York, North Carolina, Pennsylvania
2017-05-16
Active, closed
MAGE-A4ᶜ¹º³²T for Multi-Tumor
NCT03132922Urinary Bladder Cancer, Melanoma, Head and Neck Cancer, Ovarian Cancer
USWM CT, LLC
Phase 1
71
Florida, Missouri, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas
2017-05-15
Active, closed
Bolton Medical
Not applicable
110
Alabama, Arizona, California, Connecticut, Florida, Georgia, Indiana, Iowa
2017-05-10
Active, closed
Xeltis
Not applicable
6
California, Colorado, Florida, New York, Ohio, Pennsylvania, Texas
2017-05-08
Active, closed
Eli Lilly and Company
Phase 1/2
857
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana
2017-05-02
Recruiting
Agendia
Observational
30,000
Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, Florida
2017-04-28
Active, closed
Pfizer
Phase 3
296
Florida, Massachusetts, New York, Tennessee, Washington
2017-04-27
Active, closed
Bolton Medical
Not applicable
50
California, Connecticut, Georgia, Indiana, Iowa, Maryland, Massachusetts, Missouri
2017-04-17
Active, closed
Acerta Pharma BV
Phase 3
635
Arizona, California, Connecticut, District of Columbia, Florida, Georgia, Kansas, Kentucky
2017-04-05
Recruiting
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
NCT05619588Ankle Rheumatoid Arthritis, Arthritis of Ankle, Failure, Prosthesis
Exactech
Observational
370
Florida, North Carolina
2017-04-04
Recruiting
SyneuRx International (Taiwan) Corp
Phase 2/3
287
California
2017-03-29
Active, closed
AstraZeneca
Phase 3
987
Alabama, Arizona, Arkansas, California, Connecticut, Georgia, Indiana, Kansas
2017-03-27
Active, closed
Abbott Medical Devices
Not applicable
2,005
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida
2017-03-27
Recruiting
Physica System Total Knee Replacement Registry Study
NCT03048201Osteoarthritis, Knee, Traumatic Arthritis, Avascular Necrosis, Degenerative Joint Disease of Knee
Limacorporate S.p.a
Not applicable
800
California, Florida, Illinois, New York, Oklahoma
2017-03-24
Recruiting
SpectraCure AB
Phase 1/2
66
New York
2017-03-21
Active, closed
REDUCE LAP-HFREF TRIAL
NCT03093961Heart Failure
Corvia Medical
Not applicable
10
New York
2017-03-10
Active, closed
Medtronic
Observational
37,000
Georgia
2017-03-10
Recruiting
Stryker Instruments
Observational
8,000
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware
2017-03-10
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
California, Colorado, District of Columbia, Florida, Georgia, Illinois, Louisiana, Maryland
2017-03-07
Active, closed
Prospective G7 Dual Mobility Total Hip PMCF
NCT03308929Clinical Outcomes, Functional Outcomes, Radiological Outcomes, Survivorship
Zimmer Biomet
Observational
250
New Jersey, New Mexico, North Carolina, Oregon, Virginia
2017-02-28
Recruiting
InSightec
Not applicable
20
District of Columbia, Florida, Texas
2017-02-28
Active, closed
AbbVie
Phase 1
163
California, Illinois, Massachusetts, North Carolina, Tennessee, Texas, Virginia
2017-02-22
Active, closed
Hoffmann-La Roche
Phase 1/2
940
Michigan, Missouri, New York, Pennsylvania, Washington
2017-02-21
Active, closed
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03069469Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 1/2
120
California, Colorado, Florida, Massachusetts, New York, Oregon, Tennessee
2017-02-16
Active, closed
LEADERS FREE II: BioFreedom™ Pivotal Study
NCT02843633Acute Coronary Syndrome, High Bleeding Risk
Biosensors Europe SA
Not applicable
1,203
Alabama, Arkansas, California, District of Columbia, Florida, Georgia, Idaho, Illinois
2017-02-14
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
California, Colorado, Illinois, Indiana, Massachusetts, Michigan, New Mexico, South Carolina
2017-02-08
Active, closed
AbbVie
Phase 3
443
California, Georgia, Illinois, Indiana, Kansas, Kentucky, Maine, Maryland
2017-02-02
Active, closed
ITM Solucin GmbH
Phase 3
324
Arizona, California, Florida, Illinois, Michigan, Texas
2017-02-02
Active, closed
Acerta Pharma BV
Phase 3
310
Arizona, California, Georgia, Illinois, Iowa, Kentucky, Minnesota, Nebraska
2017-02-02
Recruiting
Oncotherapeutics
Phase 1
134
California, Florida, Maryland, Washington
2017-02-01
Active, closed
AbbVie
Phase 3
950
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois
2017-01-31
Active, closed
DBV Technologies
Phase 3
300
Arkansas, California, Colorado, Illinois, Maryland, Massachusetts, New York, North Carolina
2017-01-23
Active, closed
AbbVie
Phase 2
120
Alabama, Arkansas, Florida, Georgia, Illinois, Indiana, Kentucky, Maine
2017-01-19
Recruiting
PARTNER 3 Trial - Aortic Valve-in-Valve
NCT03003299Aortic Stenosis, Aortic Stenosis, Severe
Edwards Lifesciences
Not applicable
125
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana
2017-01-05
Active, closed
Genzyme, a Sanofi Company
Phase 2
12
Connecticut, Texas, Virginia
2017-01-04
Active, closed
AstraZeneca
Phase 3
669
California
2017-01-02
Active, closed
Medtronic Cardiac Rhythm and Heart Failure
Observational
6,000
Minnesota
2017-01-01
Active, closed
The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
NCT02979587Congenital Heart Disease, Tetrology of Fallot, RVOT Anomaly, Pulmonary Regurgitation
Medtronic Heart Valves
Not applicable
86
California, Connecticut, Minnesota, Ohio, Pennsylvania, Texas, Utah, Washington
2017-01
Active, closed
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
NCT02682511Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited, Sclerosis, Progressive Systemic
DrugIfetroban
Cumberland Pharmaceuticals
Phase 2
34
Arizona, California, Florida, Maryland, Massachusetts, Nebraska, New York, Pennsylvania
2017-01
Active, closed
AstraZeneca
Phase 1
117
California, Connecticut, Florida, New York, Ohio, Tennessee
2016-12-28
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Alaska, Arizona, California, Colorado, District of Columbia, Florida, Illinois, Indiana
2016-12-22
Active, closed
Janssen Biotech, Inc.
Observational
535
California, Florida, Georgia, Illinois, Ohio, Pennsylvania, Texas, Virginia
2016-12-16
Active, closed
Ribociclib (LEE011) Rollover Study for Continued Access
NCT02934568Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
DrugRibociclib
Novartis Pharmaceuticals
Phase 2
22
Alabama, Massachusetts, Michigan, New York, Tennessee
2016-12-15
Active, closed
Genentech, Inc.
Phase 1
200
Massachusetts, New York, Tennessee
2016-12-13
Active, closed
Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:
NCT03100474Essential Tremor, Parkinson's Disease, Movement Disorders, Neuropathic Pain
InSightec
Observational
500
California, Maryland, Pennsylvania, Virginia, Washington
2016-12
Active, closed
Target PharmaSolutions, Inc.
Observational
10,000
Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Illinois, Iowa
2016-12
Active, closed
Incyte Corporation
Phase 2
10
California, Kentucky, New York, Tennessee, Texas
2016-11-30
Active, closed
Eli Lilly and Company
Phase 1
223
Kentucky, New York, Texas
2016-11-21
Active, closed
Janssen Research & Development, LLC
Phase 1/2
234
Missouri, Pennsylvania
2016-11-21
Active, closed
Eli Lilly and Company
Phase 1
100
Arkansas, California, Colorado, Massachusetts, Michigan, New York
2016-11-14
Active, closed
NeoChord
Not applicable
585
California, District of Columbia, Georgia, Indiana, Maryland, Michigan, New York, Pennsylvania
2016-11-03
Recruiting
Venus Concept
Not applicable
150
California
2016-11-03
Active, closed
Gilead Sciences
Phase 2
150
California, Colorado, Indiana, Maryland, Missouri, New York, Ohio, Tennessee
2016-11
Active, closed
Eli Lilly and Company
Observational
1,400
California, Colorado, Connecticut, Florida, Georgia, Indiana, Kansas, Kentucky
2016-10-29
Active, closed
ViiV Healthcare
Phase 3
618
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois
2016-10-28
Active, closed
ViiV Healthcare
Phase 3
631
Alabama, California, Colorado, District of Columbia, Florida, Georgia, Indiana, Minnesota
2016-10-27
Active, closed
Celgene
Phase 1/2
466
Arizona, Arkansas, Georgia, Illinois, Kansas, Maryland, Massachusetts, Michigan
2016-10-14
Active, closed
Eisai Inc.
Phase 3
1,069
California, Florida, Illinois, Kansas, Louisiana, Maryland, Massachusetts, Michigan
2016-10-13
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
NCT02325674Generalised Lipodystrophy, Partial Lipodystrophy
DrugMetreleptin
Chiesi Farmaceutici S.p.A.
Observational
100
Alabama, California, Georgia, Illinois, Kansas, Louisiana, Maryland, Michigan
2016-10-11
Active, closed
Gilead Sciences
Phase 2/3
177
District of Columbia, Florida, Georgia, Michigan, New York, North Carolina, Pennsylvania, Tennessee
2016-09-21
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
California, Colorado, Florida, Georgia, Illinois, Indiana, Maryland, Massachusetts
2016-09-13
Active, closed
W.L.Gore & Associates
Not applicable
250
California, Connecticut, District of Columbia, Florida, Georgia, Illinois, Indiana, Kentucky
2016-09-06
Active, closed
Memory Gel and Shape Combined Cohort
NCT02919592Primary Breast Augmentation, Primary Breast Reconstruction, Revision Breast Augmentation, Revision Breast Reconstruction
Mentor Worldwide, LLC
Not applicable
3,603
Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois
2016-09-01
Active, closed
DePuy Orthopaedics
Not applicable
540
Colorado, Florida, New Hampshire, New Jersey, New York, North Carolina, Tennessee, Texas
2016-09-01
Active, closed
McNeel Eye Center
Not applicable
100
Idaho
2016-09-01
Active, closed
LearningRx Cognitive Training for Brain Injury
NCT02918994Traumatic Brain Injury (TBI), Acquired Brain Injury, Post COVID-19 Cognitive Impairment
Gibson Institute of Cognitive Research
Not applicable
30
Colorado
2016-09
Recruiting
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
NCT02584244Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer, Gastric Cancer
Lumicell, Inc.
Phase 1/2
66
Massachusetts
2016-08-04
By invitation
QT Ultrasound LLC
Not applicable
1,500
California
2016-08
Active, closed
W.L.Gore & Associates
Not applicable
79
California, Connecticut, District of Columbia, Florida, Georgia, Illinois, Indiana, Maryland
2016-08
Active, closed
Tesaro, Inc.
Phase 3
733
Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa
2016-07-11
Active, closed
Tesaro, Inc.
Phase 1
463
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2016-07-08
Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
NCT02744677Complex Congenital Heart Defect, Dysfunctional RVOT Conduit, Pulmonary Valve Insufficiency, Pulmonary Valve Degeneration
Edwards Lifesciences
Not applicable
108
Alabama, Arkansas, California, Colorado, Georgia, Kentucky, Massachusetts, Minnesota
2016-07-05
Active, closed
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
NCT02477878Leukemia, Myelodysplastic Syndromes, Lymphoma, Multiple Myeloma
DrugRimiducid
Bellicum Pharmaceuticals
Phase 1
10
Georgia, Kansas, New York, Oregon, Texas
2016-07
By invitation
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
NCT02796937Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
Grifols Therapeutics LLC
Phase 3
290
Arizona, Florida, North Carolina, Oregon, South Carolina, Texas
2016-07
Recruiting
Collection and Distribution of Biospecimens for Novel Research Uses
NCT03848962Cancer, Healthy, Gastrointestinal Complication, Autoimmune Diseases
iSpecimen Inc
Observational
10,000
Alabama, Massachusetts
2016-06-30
Active, closed
Celgene
Phase 1/2
130
California, Connecticut, Illinois, Massachusetts, New York, Texas
2016-06-03
Recruiting
Neurologic Stem Cell Treatment Study
NCT02795052Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases, Neurological Disorders
MD Stem Cells
Not applicable
500
Connecticut, Florida
2016-06
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Florida, Georgia, Missouri, Oregon
2016-06
Active, closed
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
NCT02805023Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
BioGenCell Ltd.
Phase 1/2
40
California, Connecticut, Maryland
2016-06
Active, closed
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
NCT02665065Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute, Leukemia, Myeloid, Acute
Actinium Pharmaceuticals
Phase 3
153
Arizona, Connecticut, District of Columbia, Florida, Illinois, Iowa, Kansas, Minnesota
2016-06
Active, closed
Janssen Research & Development, LLC
Phase 1
751
California, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri
2016-05-24
Active, closed
Eli Lilly and Company
Phase 2
309
Arizona, California, District of Columbia, Florida, Michigan, Missouri, Pennsylvania, Tennessee
2016-05-19
Recruiting
Traumatic Brain Injury and Stroke Long Term Outcome
NCT03399929Traumatic Brain Injury, Stroke
Centre for Neuro Skills
Observational
240
California
2016-05-04
Active, closed
NeuroDerm Ltd.
Phase 2
214
Arizona, Arkansas, California, Colorado, Florida, Illinois, Iowa, Maryland
2016-05-04
Active, closed
Hoffmann-La Roche
Phase 1/2
69
California, Colorado, Georgia, Illinois, Maryland, Massachusetts, Missouri, New York
2016-05-03
Active, closed
HALO Diagnostics
Observational
1,000
California
2016-05
Recruiting
Boston Scientific Corporation
Observational
100
Alabama, Idaho, Massachusetts, New Hampshire, New Jersey
2016-05
Active, closed
Candel Therapeutics, Inc.
Phase 2
187
Colorado, Illinois, Louisiana, Maryland, Missouri, Nevada, New Jersey, New York
2016-05
Recruiting
Bio-Path Holdings, Inc.
Phase 2
108
California, Georgia, Kansas, New Jersey, New York, Texas, West Virginia
2016-05
Recruiting
Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
NCT02716246MPS IIIA, Sanfilippo Syndrome, Sanfilippo A, Mucopolysaccharidosis III
Ultragenyx Pharmaceutical Inc
Phase 2/3
36
Ohio, Pennsylvania
2016-04-25
Active, closed
Acerta Pharma BV
Phase 1
72
Kentucky, Michigan, New Jersey, New York, Ohio, Tennessee, Texas, Washington
2016-04-20
Active, closed
Biodesix, Inc.
Observational
5,006
Alabama, Arkansas, California, Connecticut, Florida, Georgia, Illinois, Indiana
2016-04-04
Active, closed
Mentor Worldwide, LLC
Not applicable
400
Alabama, Arizona, California, Georgia, Indiana, Iowa, Kansas, Minnesota
2016-04-01
Active, closed
Bridge-Enhanced ACL Repair vs ACL Reconstruction
NCT02664545Anterior Cruciate Ligament Tear
Miach Orthopaedics
Not applicable
100
Massachusetts
2016-04
Active, closed
DS-3201b in Participants With Lymphomas
NCT02732275Lymphoma, Malignant, Non-hodgkin Lymphoma
DrugValemetostat Tosylate
Daiichi Sankyo Co., Ltd.
Phase 1
100
California, Connecticut, Georgia, Massachusetts, New Jersey, New York, North Carolina, Ohio
2016-03-31
Active, closed
AstraZeneca
Phase 1/2
264
Georgia, Maryland, Massachusetts, Michigan, Missouri, Ohio, Pennsylvania
2016-03-17
Active, closed
Acerta Pharma BV
Phase 2
60
Arizona, California, District of Columbia, Illinois, New York, Ohio, Tennessee, Texas
2016-03-08
Active, closed
Tesaro, Inc.
Phase 1
729
Alabama, Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Illinois
2016-03-07
Active, closed
Pentax Medical
Not applicable
150
California, Florida, Illinois, Maryland, Minnesota, New York, North Carolina, Ohio
2016-03
Active, closed
ReCor Medical, Inc.
Not applicable
282
Alabama, California, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana
2016-03
Active, closed
Medtronic Cardiovascular
Not applicable
2,223
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana
2016-03
Active, closed
Edwards Lifesciences
Not applicable
1,000
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii
2016-03
Active, closed
MedImmune LLC
Phase 1/2
383
Alabama, Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts
2016-02-22
Recruiting
InSightec
Observational
200
California, Minnesota
2016-02-16
Active, closed
Supernus Pharmaceuticals, Inc.
Phase 3
1,400
Arkansas, California, Colorado, Florida, Oklahoma, Tennessee, Texas, Utah
2016-02-02
By invitation
A Clinical Registry of Orthobiologics Procedures
NCT03011398Orthopedic Disorder
Regenexx, LLC
Observational
50,000
Arizona, California, Colorado, Florida, Illinois, Iowa, Kentucky, Louisiana
2016-02
Active, closed
BioMarin Pharmaceutical
Phase 2
30
California, Illinois, Maryland, Tennessee, Texas
2016-01-26
Active, closed
Acerta Pharma BV
Phase 1/2
24
California, Massachusetts, New York, Washington
2016-01-25
Active, closed
Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
NCT02698579Cerebral Adrenoleukodystrophy (CALD), Adrenoleukodystrophy (ALD), X-Linked Adrenoleukodystrophy (X-ALD)
Genetix Biotherapeutics Inc.
Observational
64
California, Massachusetts, Minnesota
2016-01-22
Active, closed
Geron Corporation
Phase 2/3
289
Alabama, Arizona, California, Connecticut, Florida, Indiana, Maryland, Missouri
2016-01-12
Recruiting
Vanda Pharmaceuticals
Observational
1,000
District of Columbia
2016-01
Recruiting
Stem Cell Ophthalmology Treatment Study II
NCT03011541Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa, Stargardt Disease
MD Stem Cells
Not applicable
500
Connecticut, Florida
2016-01
Active, closed
Bayer
Phase 1/2
154
California, Florida, Massachusetts, New York, Ohio, Pennsylvania, Tennessee, Texas
2015-12-16
Active, closed
Novartis Pharmaceuticals
Phase 4
233
Arkansas, California, Colorado, Maryland, New Jersey
2015-12-11
Active, closed
AbbVie
Phase 3
1,629
Alabama, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois
2015-12-01
Active, closed
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
NCT02659215Defect of Articular Cartilage
Anika Therapeutics, Inc.
Not applicable
200
Arizona, California, Connecticut, Florida, Illinois, Louisiana, Nevada, New York
2015-12
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Indiana
2015-11-27
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Alabama, Arizona, California, Colorado, Connecticut, Florida, Idaho, Illinois
2015-11-19
Active, closed
Hoffmann-La Roche
Phase 2
534
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2015-11-19
Active, closed
On-X Life Technologies, Inc.
Observational
510
Arizona, Connecticut, Indiana, Maine, North Dakota, Ohio, Oregon, Texas
2015-11-10
Active, closed
AstraZeneca
Phase 3
953
California, Kentucky, New Jersey, New Mexico, New York, Ohio, Pennsylvania, Texas
2015-11-03
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Arizona, California, Georgia, Illinois, Kansas, Massachusetts, Michigan, Minnesota
2015-11-02
Active, closed
AstraZeneca
Phase 3
1,126
California, Colorado, Connecticut, Florida, Georgia, Kentucky, Massachusetts, Michigan
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
California, Colorado, Connecticut, Florida, Georgia, Hawaii, Illinois, Maryland
2015-10-21
Active, closed
MedImmune LLC
Phase 2
433
Arizona, California, Connecticut, Florida, Indiana, Massachusetts, New York, North Carolina
2015-10-19
Recruiting
Sequenom, Inc.
Observational
3,000
Idaho
2015-10-13
By invitation
Adera Labs, LLC
Observational
250
California
2015-10
Active, closed
Curemark
Phase 3
405
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Indiana, Louisiana
2015-10
Recruiting
Karyopharm Therapeutics Inc
Phase 1/2
300
Arizona, California, Colorado, Massachusetts, Nebraska, New Jersey, New York, North Carolina
2015-10
Active, closed
JOURNEY™ II CR Total Knee System
NCT02440672Osteoarthritis, Knee
Smith & Nephew, Inc.
Observational
170
Arizona, Illinois, Maryland, New York, North Carolina, Ohio
2015-09
Active, closed
Triathlon Tritanium Cone Augments Outcomes Study
NCT02521103Arthroplasty, Replacement, Knee
Stryker Orthopaedics
Not applicable
254
Florida, Illinois, Kentucky, Michigan, Missouri, New Jersey, Oklahoma, Washington
2015-08
Active, closed
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
NCT02402660Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy, Autosomal Recessive Stargardt Disease 1 (ABCA4-related)
DrugALK-001
Alkeus Pharmaceuticals, Inc.
Phase 2
160
Arizona, California, Colorado, Florida, Indiana, Maryland, Michigan, New York
2015-08
Recruiting
Total Shoulder Arthroplasty Multi-Center Registry
NCT03511586Shoulder Arthroplasty
Arthrex, Inc.
Observational
2,500
Arizona, Colorado, Connecticut, Florida, Illinois, Indiana, Michigan, Missouri
2015-07-28
Active, closed
Acerta Pharma BV
Phase 3
533
Arizona, California, Florida, Georgia, Illinois, Kansas, Minnesota, Montana
2015-07-28
Active, closed
AstraZeneca
Phase 3
1,118
Arizona, California, Connecticut, Florida, Georgia, Hawaii, Maryland, Minnesota
2015-07-21
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Alabama, Arizona, California, Connecticut, Georgia, Illinois, Maryland, Massachusetts
2015-07-14
Recruiting
VivaTech International, Inc.
Phase 2
4,000
Pennsylvania
2015-07
Recruiting
VivaTech International, Inc.
Phase 2
4,000
Pennsylvania
2015-07
Active, closed
Medtronic
Observational
3,100
Alabama, California, Connecticut, District of Columbia, Florida, Georgia, Indiana, Iowa
2015-07
Recruiting
VivaTech International, Inc.
Phase 2
4,000
Pennsylvania
2015-07
Active, closed
LEGION Hinge Safety and Efficacy Study
NCT02445443Knee Arthroplasty, Total
Smith & Nephew, Inc.
Observational
47
Iowa, New York, Oregon
2015-06-30
Active, closed
Acerta Pharma BV
Phase 3
535
Arizona, California, Colorado, District of Columbia, Florida, Illinois, Indiana, Kansas
2015-06-26
Active, closed
MicroPort Orthopedics Inc.
Observational
150
Illinois
2015-06-15
Recruiting
Cerenome
Phase 1/2
55
New York, Ohio, Texas
2015-06-03
Rows per page Showing 8501–9000 of 9123
Previous 16 17 18 19 Next
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site. Derived from ClinicalTrials.gov. Retrieved 6 November 2026. https://priyalifescience.com/clinical-trials-usa?page=18

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,123 studies in total at the last sync on 06 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in the US?

4,958 of the 9,123 studies in this register are recruiting new participants as of the 06 Nov 2026, 03:16 UTC sync. A further 485 have not yet opened recruitment, 3,308 are active but closed to new participants, and 372 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Advanced Solid Tumor (143) Obesity (136) Breast Cancer (132) Multiple Myeloma (110) Advanced Solid Tumors (94) Overweight (87) Colorectal Cancer (86) Solid Tumor (83) Ovarian Cancer (78) Heart Failure (73) Prostate Cancer (72) Non-Small Cell Lung Cancer (72) Healthy (69) Cancer (64) Melanoma (60)
→

Browse trials by state

California (5300) Florida (4469) Illinois (2481) Georgia (2360) Arizona (2255) New York (2133) Colorado (2064) Texas (1968) Massachusetts (1839) Michigan (1470) Alabama (1308) Connecticut (1301) Maryland (1258) Ohio (1247) Indiana (1122)
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.